Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.27 | 8e-12 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.21 | 5e-08 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.21 | 8e-08 |
mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0004 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |